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Abstract
Pain has a profound effect on an animal’s wellbeing. In Germany, researchers using animals have been legally required
to reduce any possible pain, suffering, distress or lasting harm to an absolute minimum since 1972. To evaluate how
these provisions have been implemented in practice, an assessment of refinements to experimental techniques was
conducted by retrospectively reviewing 684 surgical interventions described in 506 animal research applications that
were sent to the German competent authorities for approval in 2010. This paper focuses on the efficacy of proposed
anesthesia and peri- and postoperative analgesia. Postoperative analgesia was not proposed for 30% of surgeries.
Following 10% of procedures, animals were to be given pain relieving medication if the investigators decided this
was necessary; however, structured assessments to detect pain were absent. Consequences of unalleviated pain
and omission of pain assessment techniques are discussed, and some recommendations to improve anesthesia and
analgesia are given. The findings of this review highlight the need for improvement, both to fulfil legal requirements
and to improve animal welfare. To monitor compliance with animal welfare regulations and ensure good veterinary
and scientific practices, education and training need to be intensified. Adherence to the items listed in the PREPARE and
ARRIVE guidelines and the Gold Standard Publication Checklist (GSPC) should become legally binding.

1 Introduction

Refinement, the last R of the Three Rs principles (replacement, reduction, refinement), was first described by Russell and Burch 60
years ago (Russell and Burch, 1959), and pertains to “[m]ethods
that minimize any pain, suffering, distress or lasting harm that
may be experienced by the animals, and improve animal welfare. Refinement applies to all aspects of animal use, from the
housing and husbandry to the scientific procedures performed
upon them” (Graham and Prescott, 2015). The revised Directive,
2010/63/EU, requires European Union (EU) Member States to
fully implement the Three Rs principles in their national laws
(EU, 2010). Most states amended their national legislation in
2013. Well before that, following the revision of the German
Animal Welfare Act in 1972, research workers using animals
in Germany were required to reduce any possible pain suffering, distress, or lasting harm caused to animals to an absolute
minimum (Germany, 1972). Nevertheless, due to limitations in
the transparency of the authorization processes and reporting of
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animal research, it has been difficult to assess the extent to which
experimental procedures were refined in practice.
Structured literature reviews of research that involved the use
of laboratory animals have provided some insights. Animal research involving surgical procedures carried out on pigs, sheep,
dogs, and non-human primates (Coulter et al., 2009), rabbits
(Coulter et al., 2011) and rodents (Coulter et al., 2009; Richardson and Flecknell, 2005), published in peer-reviewed journals,
has been analyzed with regard to analgesic and anesthetic administration. Stokes and colleagues (2009) focused on studies
conducted during two time periods (2000-2001 and 2005-2006)
to assess changes in the administration of analgesics and anesthetics to laboratory mice and rats undergoing surgical procedures. The study showed a trend towards improvement such
as safer anesthetic regimens used in the later period examined,
but this and an earlier review assessing analgesic use in rodents
(Richardson and Flecknell, 2005) found that there was still significant scope for refinement, especially with respect to perioperative care. Richardson and Flecknell (2005) not only screened
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the publications for postoperative analgesia but also e-mailed the
authors or the respective Animal Ethics Committees a survey to
find out when analgesia was administered independent of whether it was reported. The response rate was low (28 out of 101
papers) and only 18% of correspondents had given analgesics
but not reported it. A systematic review of anesthesia, analgesia,
and euthanasia methods used in anesthesiology, respiratory, and
critical care research published in the ten highest ranked journals
showed insufficient reporting of treatment regimens in experimental studies using small laboratory mammals; for example,
the administration of analgesics was only reported in 19% of all
painful interventions (Uhlig et al., 2015).
An assessment of papers published before 2011 and from
2014 to 2015 further confirmed that reporting of experimental
refinement methods is still poor (Carbone and Austin, 2016).
Whilst guidance documents specially written for reporting of
animal studies, e.g., the Gold Standard Publication Checklist
(GSPC) (Hooijmans et al., 2010) and the ARRIVE guidelines
(Kilkenny et al., 2010), have been available since 2010, scientific publications still cannot be relied upon to present a detailed
description of analgesia and anesthesia protocols. Most recently,
an assessment of anesthetic and analgesic regimens in publications on studies involving non-human primates once again
confirmed the lack of reporting of critical detail (Bertrand et al.,
2018). Although many journals have adopted guidelines such as
“ARRIVE”, publications continue to omit key details of study
design and conduct (e.g., Leung et al., 2018). This may be due to
a lack of appreciation by researchers of the need to include these
data in their publications. It therefore remains unclear to what
extent the experimenters did not report their refinement practices
although, for example, proper pain management may have been
provided.
Besides the lack of information regarding refinement in the
available publications, there is a general lack of transparency
within animal research, as in all European Union Member States
access to animal research proposals is generally restricted to
members of the regulatory authorities. Thus, the degree to which
refinement methods are applied in practice and the awareness of
refinement options by research workers remains uncertain.
German animal research proposals must include detailed descriptions on how all procedures and interventions are to be conducted, including precise descriptions of surgeries and the application of refinements. The most humane and refined methods have to
be used while still ensuring valid data collection; this is facilitated
by a robust and effective harm-benefit analysis. For example, if
less humane anesthetics are to be used or analgesia is withheld,
this must be scientifically justified, and the hoped-for benefits of
the research must outweigh also the additional harm.
To evaluate the use of experimental refinements in German
laboratories, we retrospectively reviewed original animal research applications submitted to the German regulatory authorities for approval in 2010. The efficacy of the proposed anesthetic and peri- and postoperative analgesic regimens, the health
monitoring, use of humane endpoints, killing methods, and the
researchers’ categorization of the severity of planned procedures
were investigated. The goal was to assess the application of
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refinements before Directive 2010/63/EU came into effect and
to make recommendations about where further improvements
could be made. To our knowledge, this is the first assessment of
its kind. In this paper, we focus on proposed anesthetic and periand postoperative analgesic regimens and discuss deficiencies
and necessary improvements.
2 Materials and methods

In Germany, reviewing and licensing animal research proposals
falls under the authority of each of the federal states. The 16 federal states have their own “competent authorities” for this task,
generally comprised of state veterinarians. After negotiations with
the highest authorities of the federal states, 14 of the 16 agreed
to provide us access to original proposals for basic and applied
research that had been granted a license. For the scope of our
study, we selected all applications submitted to the participating
competent authorities in 2010 that included recovery surgical
procedures in mice and rats to assess appropriateness of anesthesia, perioperative analgesia, and postoperative care. Mice and
rats are the two most commonly used species in Germany; over
2,000,000 mice and around 400,000 rats per year are used for
scientific purposes in Germany (BMEL, 2014, 2017). Elsewhere
in Europe, these rodents are also among the most frequently used
species (EC, 2013; Home Office, 2017). A total of 506 applications met these criteria and were included in the analysis. These
included 684 recovery surgical procedures (422 in mice and
262 in rats). The study was conducted anonymously (i.e., the
individual research groups were not identified in the analysis).
Research proposals were included in this study if they met the
following criteria:
1. Animal research proposal submitted to a German competent
authority in 2010
2. Basic or applied research study
3. Species: mouse or rat
4. Procedure: surgical, recovery
5. Original proposal that was granted a project license
Research proposals were excluded from this study if they met
the following criteria:
1. Application for the generation of genetically altered mice
2. Government-required animal testing, e.g., toxicity testing of
drugs, vaccines, pesticides
3. Species other than mouse and rat
4. Procedure that did not involve recovery surgery
5. Proposal pre-assessed or rejected by members of the competent authority
We analyzed the experimental protocols described in the original
applications. However, before approval of a final license, it is
possible, and in some cases very likely, that the competent authorities requested changes to the proposed protocols. To follow
up on the results of the competent authorities’ assessments and
on the amendments made in the process was not feasible. Also,
the scope of our study was to evaluate the researchers’ awareness
of and expertise in the application of refinement methods, not
that of the competent authorities.

ALTEX 36(1), 2019

Herrmann and Flecknell

Fig. 1: Types and numbers of surgical
procedures performed on mice and
rats
A total of 684 surgical procedures
were performed, 422 on mice and
262 on rats. “Other” refers to a general
category of all surgeries that did not
involve the opening of a body cavity,
e.g., compression or ligation of nerves,
or surgery to cause a middle cerebral
artery occlusion.

Fig. 2: Anesthetic regimens used
A total of 684 anesthetic regimens were
performed, 422 on mice and 262 on
rats.

3 Results

Some applications lacked required information. For example, in a
few cases the type, the dose, or the route of administration of an
anesthetic agent was missing; the justification as to why analgesia was withheld was mostly absent and there was generally
no discussion on why certain anesthetic regimes were selected,
even when they did not meet the standards of good veterinary
practice. Project licenses were generally granted for up to three
years, with the option to extend up to five years.
3.1 Types of surgical interventions and
frequency of endotracheal intubations
The 506 assessed applications comprised 684 surgical procedures. Some animals underwent more than one surgery or in some
cases several experimental groups underwent different surgical procedures. Out of the 684 surgical procedures, 422 were
performed on mice and 262 on rats.

ALTEX 36(1), 2019

The most frequently performed surgical procedures on mice
and rats were laparotomies. For rats, these were followed by craniotomies. For mice, the second most common procedure was
surgery that did not involve the opening of a body cavity (Fig. 1);
examples include neuropathic pain models such as compression or ligation of nerves (e.g., ischiatic nerve), implantation
of catheters in veins and arteries (e.g., femoral artery or vein,
jugular vein), a hindlimb ischemia model (ligation of the femoral artery), and a focal cerebral ischemia model (middle cerebral
artery occlusion).
Endotracheal intubation was planned for 15% of surgeries in
mice, the vast majority of these (82%) for thoracotomies, and for
8% of surgeries on rats, over half of these being for thoracotomies.
3.2 Anesthetic regimens and agents used
Injectable anesthetics were the most commonly used anesthetics
in procedures on both mice (55%) and rats (48%), followed by
inhalant agents (mice, 36%; rats, 38%) (Fig. 2). A combination
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Fig. 3: Percentage of
analgesia agents
and local anesthetics
given perioperatively
to mice and rats
Lidocaine, xylocaine,
ropivacaine, bupivacaine,
and amethocaine were
used as local anesthetics.
“Other” agents used included
paracetamol (acetaminophen),
flunixin meglumine, and
butorphanol.

of injectable and inhalational agents was used in about 10% of
surgeries (Fig. 2). The authors did not provide information on
anesthesia in 1% of surgeries. For another 1% of the surgical interventions it was not planned to use an anesthetic agent. Instead,
the investigators intended to use hypothermia (cooling the animals to 1-4°C by laying them on ice for about six minutes) to
immobilize neonatal mice and rats while carrying out intracranial injections of virions or neuroblasts.
Injectable agents used for anesthesia
Ketamine and xylazine were the most frequently used injectables in mice (79%) and in rats (70%). A completely reversible anesthetic regimen, a mixture of fentanyl, medetomidine, and midazolam, was used in 11% of mice and in 5% of
rats. Choral hydrate was frequently used in rats (6%) but was
rarely administered to mice (< 1% of procedures). Ketamine
and medetomidine were also frequently used in rats (6%) rather
than in mice (2%). Pentobarbital use ranked between 3% in mice
and 5% in rats. Other single agents used in mice were medetomidine (1%) and ketamine (< 1%). Acepromazine was
combined with xylazine and ketamine for rats (5%). In mice,
acepromazine was combined with ketamine but this was used
rarely (< 1%). The mixture of fentanyl, fluanisone, and midazolam was also used rarely for mouse and rat surgeries (2%). In
a few cases it was stated that reversible anesthetic agents would
be antagonized at the end of the procedure.
Inhalational agents
Isoflurane was by far the most widely used inhalation agent
(74% and 70% of procedures performed in mice and rats, respectively), followed by the combination of isoflurane and nitrous
oxide in both species (15%). For surgeries on mice, nitrous oxide
was also used in combination with halothane (9%) as well as
halothane alone (1%), whereas for rat surgical interventions no
halothane use was reported, but sevoflurane (8%) and methoxyflurane (7%) were used.
68

Combination of inhalational and injectable agents producing
anesthesia
The combination of inhalational agents with injectable anesthetics or sedatives was used in 9% of surgeries on mice and
13% of surgeries on rats. Here the most frequently administered
injectable agents – ketamine and xylazine – were combined with
isoflurane: 39% for mice; 56% for rats. The next most commonly used combination of anesthetics for mice was isoflurane and
ketamine/midazolam and for rats isoflurane/nitrous oxide with
ketamine/xylazine. In the majority (61%) of cases anesthetic
induction was performed with the injectable anesthetic/sedative,
followed by the use of inhalational agents. In some cases, ether
(3% of cases) or carbon dioxide (6% of cases) was used to initiate anesthesia in rats. Carbon dioxide was however frequently
used to kill animals (Herrmann and Flecknell, 2018a).
3.3 Perioperative analgesia
The most frequently used perioperative analgesic agent for both
mice and rats was buprenorphine (mice: 38%; rats: 31%), followed by carprofen (mice: 29%; rats 27%), and fentanyl (mice:
12%; rats: 7%) (Fig. 3). Local anesthetics such as lidocaine,
xylocaine, ropivacaine, bupivacaine, and amethocaine were used
in 10-13% of procedures. For instance, 22% of the craniotomies
and 10% of the thoracotomies involved the application of local
anesthetics at the surgical site. Metamizole was used in 8-9% of
cases, followed by other analgesics such as paracetamol, flunixin
meglumine, and butorphanol. Tramadol was used rarely in mice,
but was administered after 8% of surgeries on rats. Meloxicam
was a seldom administered agent in both species (Fig. 3).
When inhalational anesthetics with no or minimal analgesic properties were used, it was assessed whether and when
they were combined with analgesics. In the case of isoflurane,
25% of mice and 28% of rats received no pain relief, and
13% of mice and 18% of rats received pain relief at the end of
surgery, while the others received pain relief pre- or intraoperatively (Fig. 4).
ALTEX 36(1), 2019
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Fig. 4: Time of analgesic
administration when
isoflurane was used
Of all inhalational anesthetic
regimens, isoflurane was used
in 74% and 70% of surgical
interventions in mice and rats,
respectively.

Fig. 5: Decision on administration of analgesic treatment
following surgical interventions
(422 on mice and 262 on rats): yes, no, and “if needed” according
to the judgement of the researcher.

For injectable agents with no specific analgesic activity such
as pentobarbital or chloral hydrate we reviewed whether these
were combined with analgesics: With pentobarbital, analgesia
was not provided in 55% of surgical procedures on mice and in
75% of surgical procedures on rats. Chloral hydrate, an injectable anesthetic that was most frequently used for craniotomies in
rats, was most often combined with tramadol given intraoperatively and, less often, with a local anesthetic.
3.4 Postoperative analgesia
Postoperative analgesia was administered following 57% of the
surgical interventions on mice, less than 1% being multimodal, and
62% of procedures on rats. In only 1% and less than 2% of cases,
respectively, were these multimodal analgesic regimens (Fig. 5).
ALTEX 36(1), 2019

The surgical procedures for which multimodal analgesia was
provided postoperatively are listed in Table 1 (for mice) and 2 (for
rats). In one of the two mouse procedures, the multimodal approach was optional, depending on pain being detected. The first
three postsurgical regimens in Table 2 are identical and were used
after various surgical procedures all described in the same research
application. One of the aortic banding surgeries, a commonly used
experimental model for pressure overload-induced cardiac hypertrophy and heart failure, used the multimodal approach only in
case the animals did not drink enough, because metamizole was
supplied via the drinking water, and/or the animals showed signs
of pain. The applications involving aortic banding (Tab. 2) represent two of very few that mentioned they would monitor water
intake. One application also stated the amount that the rats were
expected to drink from 8 weeks old (8-12 ml/kg body weight).
No postoperative analgesia was intended following 32% of
surgeries on mice and 30% of surgeries on rats (Fig. 5). Reasons
for withholding analgesia were given for 24% of these surgeries
on mice and 33% of these surgeries on rats. The most frequent
explanations were that it was not considered necessary as pain
was anticipated to be minor, and that the analgesic agent could
influence study outcomes. In 11% of surgical procedures on mice
and in 8% of surgical procedures on rats the investigators declared
that they would administer analgesia only “if needed” (Fig. 5).
Pain management would be considered “when signs of pain and/
or suffering were observed” or “in case of signs of moderate
pain”. Some stated that, according to their experience, analgesia
was not necessary for the planned surgical interventions and that
the surgery was “tolerated well by the animals”. Overall, these
applications contained no description of how a structured pain
assessment would be conducted. The general health score sheets
15% of surgical procedures had included focused on various
health indicators, including humane endpoints, most of which are
not specific for pain (Herrmann and Flecknell, 2018a,b).
Similar to intraoperative pain management for mice and rats,
buprenorphine (mice: 33%; rats: 34%) and carprofen (both: 33%)
69
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Fig. 6: Postoperative
analgesic agents used
No analgesia was provided
after 32% of mouse surgeries
and after 30% of rat surgeries.
Proposed local anesthetics
were lidocaine, xylocaine and
bupivacaine. Other analgesics
included piritramide, fentanyl,
ketamine and ketoprofen.

were most commonly utilized to manage postoperative pain, followed by metamizole (mice: 20%; rats: 13%) (Fig. 6). Tramadol
was used postoperatively in 10% of surgeries in rats and in 3%
of surgeries in mice. Meloxicam was more popular after interventions in mice (4%) than in rats (2%). Other rarely used agents
were paracetamol, acetylsalicylic acid, flunixin meglumine, and
local anesthetics (Fig. 6).
Information regarding duration and frequency of postoperative analgesic application was incomplete. When indicated, buprenorphine was often given subcutaneously (s.c.) between once
and three times a day for one to three days and longer, but some
administered buprenorphine intraperitoneally (i.p.) or intramuscularly (i.m.). Carprofen was given mostly s.c., but at times i.p.,
i.m., orally, or via the drinking water. When not given via the
drinking water, it was administered once or twice daily for one
to three days, or occasionally longer. Metamizole, paracetamol,
tramadol, and acetylsalicylic acid were usually given via the
drinking water. Duration of administration of metamizole varied
between one to five days, in some cases up to seven days and
longer. Paracetamol was given mostly for two to three days. For
tramadol, the duration was rarely mentioned and for acetylsalicylic acid not at all. The route of administration of local anesthetics
was mostly not specified.
Analgesic doses given were usually within the standard published ranges with the occasional low, e.g., 2.5 mg/kg carprofen
in rats, or high, e.g., 30 mg/kg of carprofen in mice. Meloxicam
was dosed mostly at 0.2 mg/kg. Dosages for metamizole supplied
via the drinking water ranged between 1.3 mg/ml and 2.5 mg/ml.
Other doses noted were 110 mg/kg, 200 mg/kg, and 300 mg/kg.
Paracetamol was provided at 1-3 mg/ml drinking water. Tramadol
drinking water doses were 30 to 50 mg/kg/8h or 25 mg/l up to 200
mg/l drinking water. It was rarely reported whether the drinking
water intake would be measured, and how much an animal, based
on body weight, was expected to drink to assure sufficient drug
levels. A few investigators stated that they would administer the
analgesic s.c. if animals showed pain despite having the agent in
70

their drinking water. In one proposal, administration of tramadol
via the drinking water was started preoperatively. A small number
of investigators stated that they would switch to another analgesic
agent or give an additional analgesic if pain was not controlled
effectively. Some asserted that they would provide analgesia until
no more pain was observed. However, information in regard to
performing a structured pain assessment was absent.
3.5 Health and pain monitoring
Health score sheets were available for 108 out of 684 surgical procedures (15%); their quality varied. The vast majority monitored
general indicators of deteriorating health not specific to pain – such
as weight loss, alterations in body temperature, and tumor size.
When declaring that the animal’s behavior and overall health condition would be monitored, it was mostly unclear to what extent
this would be done and what would be done to alleviate clinical
signs (analgesia, special bedding or other measures of intensive
care). The planned frequency of monitoring of the animals was
mentioned for 33% of all surgical interventions, and in the majority of cases these checks were to be done once a day. More results
on health monitoring, severity of procedures, and assessment outcomes with regard to humane study endpoints and killing methods
are published elsewhere (Herrmann and Flecknell, 2018a,b).
4 Discussion

We found shortcomings in all areas we assessed. First and
foremost, pain was often not alleviated or was unlikely to be
alleviated effectively. Following 30% of surgical interventions,
no analgesia was planned, and in another 10% of procedures it
would be alleviated only if pain was observed but monitoring
generally seemed to be infrequent or lacking. Reasons for withholding analgesia, if included, may indicate not only a general
lack of monitoring, a lack of pain assessment, and a lack of pain
recognition skills; they also imply that concerns about the negALTEX 36(1), 2019
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Tab. 1: Post-procedural multimodal analgesic approaches following surgery on mice
Postoperative analgesia was administered following 57% of the surgical interventions on mice, less than 1% being multimodal.
Type of surgical intervention

Intraoperative regimen

Multimodal regimen

Sternotomy; cryoinjury-induced
myocardial infarction

Induction: isoflurane 1.5-3 Vol%;
maintenance: isoflurane 0.8-1 Vol%;
nitrous oxide 60%; O2 40%; intubation;
intercostal space infiltration with ropivacaine;
buprenorphine, 0.1 mg/kg i.p.; carprofen,
5 mg/kg s.c.

Buprenorphine, 0.1 mg/kg i.p., 3x/d,
duration: 5 d; carprofen, 5 mg/kg s.c.,
1x/d, duration: 10 d

Craniotomy; chronic cranial window
preparation (bone flap removal and
replacement by glass cover)

Ketamine, 130 mg/kg and xylazine,
10 mg/kg i.p.; carprofen, 5 mg/kg s.c.,
buprenorphine, 0.05 mg/kg i.p.

Carprofen, 5 mg/kg s.c.; duration: 3 d;
if pain detected: buprenorphine,
0.05 mg/kg i.p.

Tab. 2: Post-procedural multimodal analgesic approaches following surgical interventions on rats
Postoperative analgesia was administered following 62% of procedures on rats, 2% being multimodal.
Type of surgical intervention

Intraoperative regimen

Multimodal regimen

Laparotomy; clamping of Ligamentum
hepatoduodenale (Pringle maneuver);
ischemia for 30 minutes

Buprenorphine, 0.05-0.1 mg/kg s.c.;
isoflurane: induction, 4-5 Vol%;
maintenance, 1.5-3 Vol%

Carprofen, 5-10 mg/kg s.c. 1x/d;
buprenorphine* s.c. 2x/d, duration: 3 d

Laparotomy; 2/3-hepatoectomy
(in some groups combined with
30 minute-Pringle maneuver)

Buprenorphine, 0.05-0.1 mg/kg s.c.;
isoflurane: induction, 4-5 Vol%;
maintenance, 1.5-3 Vol%

Carprofen, 5-10 mg/kg s.c. 1x/d;
buprenorphine* s.c. 2x/d, duration: 3 d

Laparotomy; placing of gastrointestinal
tube

Ketamine, 40-50 mg/kg and xylazine,
1-2 mg/kg i.p.

Carprofen, 5-10 mg/kg s.c. 1x/d;
buprenorphine* s.c. 2x/d, duration: 3 d

Partial sternotomy; aortic banding

Ketamine, 80-100 mg/kg and xylazine,
1.5-5 mg/kg i.p.; injection of carprofen*
at the beginning (route not further specified);
intubation; injection of metamizole* at end
of procedure (route not further specified)

Metamizole* via drinking water for 3 d;
carprofen* s.c. 1 d (longer if needed)

Partial sternotomy; aortic banding

Ketamine, 80-100 mg/kg and xylazine,
1.5-5 mg/kg i.p.; intubation; metamizole*
s.c. at end of procedure

Metamizole, 0.05 g in 50 ml drinking
water mixed with 0.25 ml 20% glucose
solution for 3 d; if needed additionally
carprofen* s.c. 1x/d

Placement of titanium implant on two
critical size defects (5 mm diameter)
per scull

Ketamine, 90 mg/kg and xylazine, 10 mg/kg i.p.

Carprofen, 5 mg/kg 2x/d; buprenorphine,
0.05-0.1 mg/kg 2x/d, both s.c.; duration:
1 d, max. 2 d

*no dose given

ative effects of analgesics on study outcomes were greater than
the concerns about untreated pain.
Considering the severity of planned surgical interventions, it
was unexpected that use of multimodal analgesia was almost
non-existent. Furthermore, preventive analgesia was often not
provided as, for example, anesthetics that have no analgesic properties (e.g., isoflurane) were to be used; this was the case in a
quarter of these procedures, and in another 13-18%, analgesia was
planned to be given too late, and thus, the animals would recover
consciousness without pain relief. Moreover, the use of local anesthetics for severe surgeries such as thoracotomies was very low
(10% of thoracotomies).
In the following, we discuss the problems we identified in detail
and provide some information as to how these could be improved
or resolved. We are confident that implementation of these re-

finements would both significantly improve animal welfare and
improve the quality of data obtained.
4.1 Unalleviated pain
As we found that pain management during and after surgery was
often absent or inadequate, we commence the discussion with
general considerations on the effects of unalleviated pain. Researchers often appear to be concerned that (side)effects produced
by analgesics (and anesthetics) could potentially influence or even
confound study outcomes and data (as also seen in our study sample). However, there is an abundance of information on the pharmacodynamics, pharmacokinetics, unwanted effects, toxicity, and
interactions of analgesics and anesthetics with other drugs (e.g.,
Flecknell, 2016; Gaynor and Muir, 2014; Grimm et al., 2015; Muir
and Hubbell, 2014; Informationssystem CliniPharm CliniTox1 ) to

1 CliniPharm Wirkstoffdaten. http://www.vetpharm.uzh.ch/perldocs/index_i.htm
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guide investigators when designing their studies. In addition, there
is an increasing number of recommendations for the refinement
of certain models and procedures, for example, for models of
ischemic stroke (Percie du Sert et al., 2017), for rheumatoid arthritis (Hawkins et al., 2015), for sepsis and septic shock (Lilley
et al., 2015), for experimental autoimmune encephalomyelitis
(EAE) (Wolfensohn et al., 2013a), and for procedures involving
seizures, convulsions, and epilepsy (Lidster et al., 2016; Wolfensohn et al., 2013b). These guidelines were composed by experts
based on their knowledge of the particular models and the value
of potential refinements. Furthermore, specialists in veterinary
anesthesia and analgesia in a research setting can give additional,
project-specific advice and guidance.
Unalleviated pain has profound effects on the animal, leading
to emotional, behavioral, and physiological changes (see Jirkof,
2017; Peterson et al., 2017). The immune system is suppressed
due to pain stimulating glucocorticoid and catecholamine
release. Responses to pain vary between individuals, and consequently are hard to predict, which potentially makes pain a
poorly controlled study variable. In comparison, the influence of
anesthetic and analgesic agents on the data is more foreseeable
than the effects of unalleviated pain, distress, and suffering on
in vivo research. In addition, use of perioperative analgesics – if
based on the need of the individual animal elicited by properly
and frequently conducted structured pain assessments – will
most likely have relatively minor effects on the animal model.
Confounding effects are more likely to be introduced by analgesics when the agents are given over an extended time period
or in unnecessarily high dosages. The likely effects are often
overestimated and based on studies in which analgesics were
administered at elevated doses and for time periods longer than
needed in most experimental settings (e.g., Hall et al., 1996).
Furthermore, models designed to be of relevance to clinical
conditions in humans should be treated as in the human setting,
where pain would generally be alleviated whenever possible. A
plan for adequate and controlled pain management should be
developed as part of the study protocol. To sufficiently manage
pain, the choice of anesthetics and analgesics, their dose, administration route, frequency and duration of treatment, and a pain
assessment plan should be tailored to the individual research
project, treatment group and, if necessary, to an individual animal’s needs.

in small rodents but it is relatively easy to perform with the correct apparatus (Flecknell, 2016).

4.2 Need for refinement of anesthetic protocols
Endotracheal intubation
Intubation was performed in 8% and 15% of surgeries (rats and
mice, respectively), and the majority of these were thoracotomies. When opening the thoracic cavity, endotracheal intubation
is generally indicated as the animals require mechanical ventilation to maintain respiratory function. In addition, there are
certain disease models where intubation and mechanical ventilation is of considerable benefit. For example, the lesion size in
experimental models of stroke is influenced by cerebral blood
flow and the degree of cerebral vasodilation. These variables are
markedly affected by changes in arterial carbon dioxide, which
can be maintained at a consistent level by mechanical ventilation
(Liu et al., 2009). Tracheal intubation might appear challenging

Use of ketamine or medetomidine as the sole agent
There were few cases for which the use of ketamine or medetomidine as single agents was planned. Used alone, these agents
cause sedation and mild to moderate analgesia, but they must be
combined with other agents to produce surgical anesthesia. The
combination of ketamine with acepromazine or with midazolam does not usually provide an anesthetic depth necessary for
surgery in either species (Flecknell, 2016); hence, for surgical
interventions, additional agents are needed.
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Hypothermia
For experiments where neonatal mice and rats were to be injected
intracranially, the researchers planned to use hypothermia to immobilize them. The investigators would then inject the animals’ brains
with virions or neuroblasts. In neonatal rodents, the nociceptive
pathways are thought to be not yet fully developed (Fitzgerald,
2005). However, recovery from hypothermia is possibly associated
with pain as it has been shown to lead to c-Fos activation (Rhodes,
2009). Since there are anesthetic agents available for neonatal
mice and rats such as methoxyflurane (Danneman and Mandrell,
1997) or fentanyl/fluanisone (Clowry and Flecknell, 2000), the use
of hypothermia should be abandoned. It is our understanding that
the German competent authorities generally do not allow this controversial practice (Projektgruppe der Genehmigungsbehörden,
personal communications, 2016).
Pentobarbital
A number of surgical interventions were conducted under the
hypnotic agent pentobarbital, given intraperitoneally. Doses
ranged from 36 mg/kg body weight up to 60 mg/kg in mice and up
to 70 mg/kg in rats whereas recommended doses are between 4050 mg/kg (Field et al., 1993). Pentobarbital has a narrow safety
margin and is best used to provide a light plane of anesthesia
rather than for surgical interventions, for which doses close to
the lethal dose may be required (Flecknell, 2016). The high pH
of pentobarbital (11) causes pain when injected intraperitoneally. Pentobarbital also results in prolonged sleep time in rats
(120-240 min) and mice (120-180 min) (Flecknell, 2016), and
during this period, animals have depressed cardiovascular and
respiratory systems and are susceptible to hypothermia.
Chloral hydrate
Choral hydrate was rarely used in mice, but was the second most
frequently used agent in rats. However, it can cause adynamic
ileus in rats (Fleischman et al., 1977) and it often produces only a
light plane of anesthesia. Most investigators using choral hydrate
planned to give perioperative analgesia. Nonetheless, due to the
danger of causing adynamic ileus, chloral hydrate should be replaced by more effective and safer agents (Baxter et al., 2009).

Use of inappropriate inhalational agents for induction
of anesthesia
For rats, ether was used in 3% and carbon dioxide in 6% of protocols to initiate anesthesia. Induction with both of these agents
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is distressing and aversive due to irritation of the mucus membranes. Coughing, salivation, and at times laryngospasm occur
from inhaling ether (Flecknell, 2016). Carbon dioxide is strongly
aversive, and causes distress and fear in rodents (e.g., Chisholm
et al., 2013; Kirkden et al., 2008; Leach et al., 2002a,b, 2004;
Makowska and Weary, 2009; Marquardt, 2013; Niel and Weary,
2007; Niel et al., 2008; Wong et al., 2013; Ziemann et al., 2009)
and thus, its use as a killing agent has been controversial for
many years. Rats and mice are unwilling to tolerate exposure
to CO2 long enough to lose consciousness (Leach et al., 2002b,
2004; Niel and Weary, 2007; Niel et al., 2008). Food incentives
to stay in the gas chamber (Leach et al., 2004; Niel and Weary,
2007) and withholding food for up to 24 hours to increase their
motivation to stay in the chamber longer as well as varying the
gas flow rates did not change the time they were willing to tolerate carbon dioxide (Niel et al., 2008). When comparing carbon
dioxide to other anesthetic gases, it was found to be the most
aversive gas for both mice and rats, with the least aversive being
enflurane and halothane for mice and halothane for rats (Leach
et al., 2002a). Other studies compared rats’ aversion to carbon
dioxide with isoflurane or halothane exposure and concluded
that the fluorinated hydrocarbons were less aversive than carbon dioxide (Kirkden et al., 2008; Makowska and Weary, 2009;
Wong et al., 2013; Young, 2006).
Recommendations
Dosing and route of administration
Drug doses vary between species, strains, and individuals and
depend on age, sex, and health condition of the individual animal
(Flecknell, 2016). Therefore, we only discuss chosen dosages if
they were outside of the standard range. Injectable anesthetics
were the most widely used agents in both mice and rats. They
can provide safe and effective anesthesia, but this is most easily
achieved when given intravenously, so that the dosage can be
adjusted to provide the desired effect in that particular animal.
However, this is generally not feasible for small rodents, who thus
receive most injectable anesthetic agents intraperitoneally (i.p.)
and less often subcutaneously (s.c.) or intramuscularly (i.m.).
Several studies have shown that intraperitoneal applications have
a high failure rate (6-20% for experienced personnel) with some
of the material being injected, e.g., into the fatty tissues, viscera,
or caecum (Ballard, 2009; Coria-Avila et al., 2007; Gaines Das
and North, 2007; Lewis et al., 1966). Intramuscular injections
can be painful, and in the case of ketamine, for example, they can
produce necrosis (Smiler et al., 1990). The subcutaneous route
seems the least invasive, however, data comparing the accuracy
of dosing with i.p. administration is not available. Since injectable anesthetics are administered as a single dose, overdosing
or underdosing can easily occur. To avoid complications, agents
with a wide safety margin should be used as well as agents whose
effects can be reversed using specific antagonists.

Reversible anesthetic agents
Due to their small body size, rodents are prone to hypothermia,
and respiratory and cardiovascular depression (Fleischmann et
al., 2016), and mortality increases with prolonged postsurgical
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sleep time. This risk can be reduced by using anesthetic agents
that can be reversed such as medetomidine and xylazine with
atipamezole; midazolam with flumazenil and fentanyl with butorphanol, buprenorphine or naloxone. Some researchers who
used reversible anesthetic regimens planned to antagonize these
at the end of the procedure. This should be done routinely to
avoid long sleep times and ensure a faster recovery.
Most investigators in our study sample used ketamine and
xylazine, a regimen associated with prolonged recovery periods
(Albrecht et al., 2014). Ketamine/xylazine and ketamine/medetomidine could be partially antagonized with atipamezole; this
should be considered to reduce recovery time.
Pre-medication and balanced anesthesia
Isoflurane was the most frequent inhalational anesthetic used. There
seems to be a general trend towards using inhalant anesthetics,
probably because induction is rapid, anesthesia levels can be adjusted to the individual animal’s needs, and recovery from anesthesia is fast. Isoflurane undergoes almost no biotransformation;
however, it is mildly pungent (Eger, 1981). Most commonly used
inhalational agents are to some degree pungent to rodents, and
studies have shown increased aversion and distress after repeated
exposure to, e.g., isoflurane and halothane (Makowska and Weary,
2009). Hence, it is advisable to use pre-medication such as fentanyl/fluanisone or midazolam/fentanyl for induction before maintenance with an inhalational agent. Other commonly used pre-medication agents are medetomidine, dexmedetomidine, or xylazine.
Another advantage of using sedatives and analgesics as
pre-anesthetic medication is that this produces a balanced anesthesia where the dosage of each component can be reduced,
while inducing general anesthesia of sufficient depth with fewer
side effects. For example, administration with midazolam and
fentanyl has been shown to improve sevoflurane anesthesia for
moderately painful surgeries in mice (Lipiski et al., 2017). Depressant effects of sevoflurane on the respiratory rate and the
negative post-anesthetic effects on heart rate were decreased by
use of pre-anesthetic medication.
Hence, to avoid unnecessary animal distress as well as to
minimize potential negative effects of anesthesia on the research
subject, balanced anesthesia should be the norm.
4.3 Inadequate analgesia
Lack of preventive analgesia
When anesthetics with no or minimal analgesic properties were
used, e.g., in the case of isoflurane, 25% of mice and 28% of rats
received no pain relief, and 13% of mice and 18% of rats received
pain relief only at the end of surgery. Anesthetic agents without
analgesic properties such as isoflurane and sevoflurane should always be combined with analgesics to ensure sufficient pain relief
at the time the animal regains consciousness (Flecknell, 2016;
Miller and Richardson, 2011). Since most analgesics only reach
full onset of action 15 to 45 minutes after administration, it is
advisable to administer the analgesic preoperatively. Preventive
analgesia reduces both noxious stimuli reaching the central nervous system during surgery and peripheral inflammation (Miller
and Richardson, 2011). Perioperative analgesics may also have
an anesthetic sparing effect (Penderis and Franklin, 2005).
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Lack of use of local anesthetics
Splash blocks (instillation of local anesthetics at surgery site)
were used in 22% of craniotomies; for 10% of mice and rat
thoracotomies local anesthetics were used for intercostal infiltration or as splash blocks. Incorporating local anesthetics into
intraoperative regimens of surgeries known to cause severe pain
is a valuable refinement. Combining lidocaine (10 mg/kg) and
bupivacaine (5 mg/kg) provides safe and effective analgesia in a
range of species (Flecknell, 2018).
Absence of multimodal analgesia
Multimodal analgesia, the use of different classes of analgesics,
including local anesthetics, opioids, and nonsteroidal anti-inflammatory drugs (NSAIDs) in combination, represents current best
practice. Besides this approach being the most effective in managing pain, it also helps to avoid side effects caused by the use
of high doses of a single analgesic agent (Miller and Richardson,
2011; Flecknell, 2016). However, in the reviewed studies, multimodal analgesia was rarely chosen.
Intake via the drinking water
The sole application of an analgesic agent in the drinking water
was a frequent method of analgesic administration, but effectiveness of this approach for managing pain is highly questionable
as it is uncertain if the individual animal consumes sufficient
analgesic to reach effective plasma concentrations (Sauer et al.,
2016). This is especially difficult to achieve during the light
phase of the animal’s photoperiod when mice and rats drink
infrequently (Graf et al., 2016). An additional problem can be
the unfamiliar taste of the medicated drinking water. To accustom the animals to the water mix, provision should start a day
or two before the surgical intervention (as planned in one of
the reviewed proposals). A recent study demonstrated that the
mixture of tramadol and paracetamol was voluntarily consumed
via the drinking water in sufficient amounts to alleviate mild to
moderate postsurgical pain (Jirkof et al., 2018). It was concluded
that this protocol should at least partially alleviate pain, but the
authors considered that additional analgesic agents would be required after surgical interventions that caused more severe pain.
Analgesic delivery via the drinking water should be combined
with another analgesic, given by injection, to provide analgesia
during the light phase of the animal’s photoperiod when water
intake is decreased (Sauer et al., 2016). It is also practicable to
train animals to consume analgesics in a palatable base, and to
dose animals individually in this way (Kalliokoski et al., 2011;
Leach at al., 2010).
Studies on the efficacy of the oral application of metamizole,
an agent that seems especially popular in German laboratories
(see Fig. 3 and 6), appear lacking. Metamizole is a pyrazolone
derivate with antipyretic and analgesic properties. Its use in
medical practice has been prohibited in many countries since the
1970s after its use was linked to agranulocytosis. However, it
appears that the risk of metamizole-induced agranulocytosis was
exaggerated (Jasiecka et al., 2014) and the agent continues to
be available in Germany. A study to verify if it is an effective
postoperative analgesic in rodents is urgently needed.
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Analgesic dosing
Analgesic doses should be selected according to the anticipated
and then actual severity of the surgical intervention, the strain and
the animal’s individual response to the treatment (Wright-Williams et al., 2013). The general dose recommendations for carprofen given to mice are 4-5 mg/kg (e.g., GV-SOLAS and TVT,
2015) and for ketoprofen 2-5 mg/kg (Matsumiya et al., 2012).
Depending on the degree of acute pain, a 2- to 4-fold higher dose
can be needed for the analgesic to be efficient (Matsumiya et al.,
2012). However, these increased doses of NSAIDs may result in
undesirable side effects such as gastrointestinal ulceration.
Meloxicam, at the doses proposed, is unlikely to be effective in
managing postoperative pain since significantly higher doses are
required (Roughan et al., 2016; Wright-Williams et al., 2007).
A recent re-assessment of the efficacy of meloxicam for postlaparotomy pain in mice suggested that it had anti-inflammatory
activity but failed to prevent pain, even at high doses (Roughan
et al., 2016). A slow-release formulation of meloxicam also did
not control pain of rats after skin incision under general anesthesia (Seymour et al., 2016).
Slow release formulations
Repeated handling and restraint causes distress (Balcombe et al.,
2004; Meijer et al., 2006) and can add to postsurgical pain in
newly operated animals (Jirkof et al., 2015). Thus, the frequency of analgesic injections should be minimized. However, the
serum concentrations for, e.g., buprenorphine (Temgesic® ) indicate that its duration of action in mice is less than 8 hours (Jirkof
et al., 2015). Thus, to maintain effective serum concentrations,
this agent should be given at approximately 6-hour intervals.
Slow-release formulations could be administered to reduce this
to once every 24-48 hours in mice (Jirkof et al., 2015; Kendall,
2016) and up to once every 72 hours in rats (Foley et al., 2011;
Chum, 2014). However, these slow-release formulations are currently only available in the USA.
Non-provision of analgesia: reasons, responsibilities, and
refinement
Approximately 30% of surgeries on mice and rats were not to
be followed with any postoperative analgesia. However, pain
occurrence is to be expected for all surgical procedures. Annex
VIII of Directive 2010/63/EU (similar to previous guidance
documents on severity of procedures) classifies “surgery under
general anaesthesia and appropriate analgesia, associated with
post-surgical pain, suffering or impairment of general condition”
as moderate in severity and “surgical and other interventions in
animals under general anaesthesia which are expected to result in
severe or persistent moderate postoperative pain, suffering or distress or severe and persistent impairment of the general condition
of the animals” as severe (EU, 2010). In contrast, almost 40% of
the 684 surgeries included in our review were classified as mild by
the researchers (Herrmann and Flecknell, 2018b). Explanations
for not expecting and not detecting pain might be the overall low
frequency of observation of the animals, the absence of structured
pain assessments, as well as a general lack of knowledge about
pain-related behaviors in mice and rats and the impact/severity of
surgical interventions performed on them.
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Ensuring that the animals used in procedures experience the
minimum of pain, distress, and suffering is one of the investigator’s primary responsibilities (Germany, 1986). Research
applications for surgical procedures not planning to provide
postoperative pain management with no scientifically plausible
explanation should not be approved. If withholding pain relief is
indeed necessary from a scientific standpoint, the harm-benefit
analysis has to demonstrate that the anticipated benefit of the
research outweighs and thus justifies the painful experience for
the animal. When analyzing the restrictions of research studies
in detail, a solution/compromise can often be found. It might not
be possible to provide the animal with the best available pain
management, but it is almost always possible to improve the
animal’s welfare, at least by avoiding factors that can cause and
increase pain and distress. Appropriate intra- and postoperative
measures also help the animals to recover more rapidly.
Postsurgical pain is likely to be present for at least 48 hours
after surgery, and for longer when more invasive procedures
such as thoracotomies or orthopedic procedures are undertaken.
Since all opioids that are currently available in the EU act for
less than 8 hours, repeated administration will be required to
provide effective analgesia. When used alone, particularly in
mice, NSAIDs provide insufficient analgesia following major
surgery. Although handling and restraint to administer additional analgesics can cause stress, prior positive reinforcement
training of the animals and use of tunnel handling of mice can
greatly reduce this adverse effect. In any event, the stress of
handling is likely to be minimal in comparison to unalleviated
post-surgical pain.
4.4 Lack of recognition and assessment of pain
For 10% of all surgical procedures, the researchers stated that
analgesia would not be necessary, but would be provided if signs
of pain or suffering were observed. As mentioned before, information concerning structured pain assessment was generally absent. Our findings correlate with results from a study conducted
in the UK where almost none of the 28 institutions in the survey
used pain assessment methods. Although their efficacy was not
assessed, the British laboratories routinely provided the animals
with analgesics (Hawkins, 2002).
In many cases, investigators stated that animals would be
monitored “frequently” without defining what this would mean.
When the frequency of health inspections was specified, most
of these checks were to be done once a day. Yet, daily inspections are a minimum legal requirement for healthy animals (EC,
2007). Even before Directive 2010/63/EU was published, recovery surgical procedures were generally rated as at least moderate
in severity (Martini et al., 2000). Thus, animals that have undergone surgery require much more frequent monitoring to assure
that pain is recognized and managed effectively.
Recommendations
Positive reinforcement training
The degree to which pain is perceived and the way the presence
of pain is expressed by animals varies greatly between species,
strains, sexes, age, health status, as well as among individuals.
Therefore, proper pain assessment schemes are necessary as it
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is insufficient to administer an analgesic and assume that pain is
alleviated. Observations to assess pain are more likely to be successful when animals are familiar with the people who observe
and handle them and provide veterinary care. This highlights the
importance of frequent positive interactions with the animals.
Besides gentle handling practices (Hurst and West, 2010; Gouveia and Hurst, 2013), successes of positive reinforcement training in mice (Leidinger, 2018) and rats (Schuppli et al., 2017)
leading to positive animal-human relationships that could help
with ensuring their pain is managed effectively.
Monitoring criteria
Common behavioral alterations in mice and rats that can indicate
pain are, e.g., decreased activity levels (Wright-Williams et al.,
2007; Karas, 2002), sleep disturbances, reduced water and food
intake (Liles et al., 1993; Carstens and Moberg, 2000), changes
in nest building (Deacon, 2012; Jirkof et al., 2013; Jirkof, 2014),
burrowing (Deacon, 2006, 2009, 2012; Jirkof et al., 2010; Jirkof,
2014), and grooming behavior (Miller et al., 2016). Specific
behaviors associated with abdominal pain in rodents include
pressing the abdomen against the cage floor, raising the tail
while walking, flinching, twitching of back muscles, partial loss
of balance when walking, and lifting one leg straight out behind
(Wright-Williams et al., 2007; Leach et al., 2012; Miller et al.,
2012, 2016). The observation and scoring of these behaviors can
be complemented with monitoring of burrowing and nest building behaviors as in some strains these have been shown to be
useful not only for disease progression, but also as signs of pain
and distress (Jirkof, 2014). A prerequisite is that baseline data is
obtained for the particular strain.
Another approach to pain assessment is the use of the grimace
scale for mice (Langford et al., 2010; Leach et al., 2012) and rats
(Sotocinal et al., 2011). The Mouse Grimace Scale (MGS) and
Rat Grimace Scale (RGS) have been used successfully to assess
spontaneous, postoperative pain that can be detected for 36 to
48 hours after surgery (Matsumiya, 2012). For research purposes, the MGS and RGS are used by scoring images taken from
digital video. This system also has been used by animal care
staff and research workers (Matsumiya, 2012), who confirmed
user friendliness and sensitivity of the method (e.g., Faller et al.,
2015). Using multiple blinded observers, previously overlooked
low-level pain was identified in a study where the system was
used to assess the efficacy of postsurgical analgesia protocols
following thoracotomy for surgical induction of myocardial infarction (Faller et al., 2015). Furthermore, this tool has shown
potential in the search for effective analgesic dose ranges. The
use of the MGS showed that currently recommended doses of
carprofen and ketoprofen were insufficient to manage postsurgical pain, and that paracetamol was an inadequate agent at any
dose (Matsumiya et al., 2012). The grimace scale should be combined with monitoring other pain-related behaviors mentioned
above, water and food intake, locomotor and exploratory activity, as well as changes in nest building and burrowing behavior
in order to optimize pain management strategies. Structured pain
assessments take time and therefore require sufficient numbers
of trained personnel. However, they are central to assuring the
efficacy of analgesic treatment.
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Monitoring in the nocturnal phase
Rodents are generally more active in the dark phase of their
photoperiod (Wells, 2017), so other useful tools to employ are
remote video-monitoring of animals in their home cage and, in
certain settings, the use of automated cages that are able to detect and record rapid changes in normal behavior (Miller et al.,
2011; Wright-Williams et al., 2013; Jourdan et al., 2001). Limitations of currently available automated cages are that abnormal
behaviors which are associated with pain such as pressing the
abdomen on the cage floor or slow contortion of abdominal flank
muscles are not detected.
5 Conclusions

The findings of this first-of-its kind review of original animal
research proposals confirms international trends detected in various previous appraisals (see also Bara and Joffe, 2014; Taylor,
2010; Pound and Nicol, 2018; Uhlig et al., 2015). Although
reporting of analgesia and anesthesia in scientific publications
is often incomplete, it is highly probable that, for example, postoperative analgesia was not provided if it is not mentioned in
the publication. Our assessment shows that legal requirements
to comprehensively apply available methods of refinement were
not followed in the study sample. In particular, provision of
pain management was often either not planned or the proposed
regimens were not appropriate, and optimal techniques such
as multimodal analgesia were almost never used to alleviate
postoperative pain in laboratory rodents. Pain assessment tools
and schemes were not utilized, and effective health monitoring seemed to be lacking. To assess whether the situation has
changed since Directive 2010/63/EU came into effect in 2013,
it would be important for this study to be repeated, as well as
expanded to other EU Member States.
Since animal research workers are legally bound to reduce
discomfort, pain, and suffering of animals to an absolute minimum, a possible explanation for the deficiencies in the research
applications is that they have not received sufficient education
as well as adequate on-going training in refinement methods and
animal welfare.
The number of investigators who underestimated the severity
of their procedures (see Herrmann and Flecknell, 2018b) also
suggests there is a knowledge gap. To ensure that animal research is conducted in the most responsible and least invasive
way, resulting in findings that are valid and reproducible, professional assistance and comprehensive training are required. It is
important to educate researchers not only on how experiments,
husbandry, and care could be refined, but also why this is central to producing high quality research data. To adhere to all the
Three Rs, specialists in reduction, replacement, and alternative,
animal-free approaches should also be consulted during study
planning. Every research institution should ensure that these
experts are available to advise and assist research workers when
planning, designing, conducting, and reporting their studies; and
if a research institution does not have such expertise, outside
specialists should be sought. Education and training is one of
the focus areas of the new Directive, and a guidance document
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to improve and harmonize education and training in the EU was
produced by an Expert Working Group (National Competent
Authorities, 2014). Incorporating the learning outcomes into
the relevant training modules and ensuring that all new research
workers attend formal courses to deliver this training effectively
should improve the implementation of refinements. Refresher
training for more experienced researchers is recommended and
more formal requirements for this should also be considered.
It is critical that clear descriptions regarding the provision
of adequate pain management (and all other refinements) are
included in research proposals and in publications to avoid
needless pain and suffering of the animals. Full disclosure in
the proposals and in the publications is also essential to enable
the replication of the studies and to understand the findings.
Researchers build their work on the work of other researchers,
mostly by using information given in publications, and regulatory authorities and bodies, such as animal research and ethics
committees, Animal Welfare Bodies (AWBs), and Animal Care
and Use Committees (ACUCs), make their decisions on the content presented in proposals. Hence, openness about all aspects
and details is imperative.
Finally, investigators should closely follow the PREPARE
(Smith et al., 2017) and ARRIVE guidelines or the Gold Standard
Publication Checklist (GSPC) to provide essential data required
for interpretation of their results. Funding agencies and scientific
journals still do not demand full disclosure of this information
(Baker et al., 2014; Carbone and Austin, 2016; Enserink, 2017;
Reichlin et al., 2016). A recent randomized controlled trial of an
Intervention to Improve Compliance with the ARRIVE guidelines revealed that the request to fill in an ARRIVE checklist did
not lead to full compliance with the guidelines in the manuscript
(Hair et al., 2018). Thus, legal enforcement of compliance with
preparation and reporting checklists, in addition to comprehensive training on all checklist items, appears critical to fulfil
already existing legal requirements as well as responsibilities to
the public, who ultimately funds research and, as opinion polls
(e.g., Clemence and Leaman, 2016) show, expects that suffering
is minimized.
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